SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker. Wu W, Lu P, Patel P, Ma J, et al. Oncogene 2023;42:409-420.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu W, Lu P, Patel P, Ma J, et al. SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker. Oncogene 2023;42:409-420.
PMID: 36482202